Lv61
3190 积分 2023-10-10 加入
Generative AI and large language models in nuclear medicine: current status and future prospects
2小时前
已完结
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data
11天前
已完结
The emerging role of lactate in tumor microenvironment and its clinical relevance
24天前
已完结
Neoadjuvant therapy in renal cell carcinoma with tumor thrombus: A systematic review and meta-analysis
1个月前
已完结
Novel LINC01923-anaplasticlymphoma kinase rearrangement identified in advanced lung adenocarcinoma with durable response to ensartinib: a case report
4个月前
已完结
Glioma
5个月前
已完结
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
5个月前
已完结
Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Become the Standard of Care
5个月前
已完结
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer
5个月前
已完结
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
